. Changes in Serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and matrix metallopeptidase-2/9 (MMP-2/9), serum CD3+, CD4+, and CD8+ in patients undergoing thoracoscopic surgery for non-small-cell lung cancer
Serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and matrix metallopeptidase-2/9 (MMP-2/9), serum CD3+, CD4+, and CD8+ in patients undergoing thoracoscopic surgery
Abstract
Abstract
Objective: Non-small-cell lung cancer (NSCLC) remains one of the most common malignancies worldwide, posing a great potential threat to the health and life safety of patients. Methods: One hundred and fifty NSCLC patients admitted to our hospital from September 2022 to September 2023 were selected, inflammatory response, changes in T-lymphocyte subpopulations before and after surgery were detected, and patients' psychological status was investigated. Finally, patients were followed up for 6 months to record the prognostic survival rate. Results: Postoperative inflammatory factors and CD8+ were lower in the research group than in the control group, while CD3, CD4+ and CD4/CD8+ were higher than in the control group (P<0.05). Meanwhile, the psychological status of the research group was better. But there was no difference in prognostic survival between the two groups (P>0.05). Conclusion: Perioperative refinement of care can optimize the surgical process in patients with NSCLC, and the cellular immune function was enhanced.
References
1. Duma N, Santana-Davila R, Molina JR (2019) Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clin Proc 94 (8): 1623-1640. doi: 10.1016/j.mayocp.2019.01.013
2. Mithoowani H, Febbraro M (2022) Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology. Curr Oncol 29 (3): 1828-1839. doi: 10.3390/curroncol29030150
3. Pang M, Jiang Y, Huang Y, Ren B, He L, Jiang L (2023) MiR-654-3p targets SRC to suppress tumor growth in non-small cell lung cancer. Cell Mol Biol (Noisy-le-grand) 69 (4): 157-163. doi: 10.14715/cmb/2023.69.4.25
4. Jonna S, Subramaniam DS (2019) Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med 27 (148): 167-170. doi:
5. Nagano T, Tachihara M, Nishimura Y (2019) Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Curr Cancer Drug Targets 19 (8): 595-630. doi: 10.2174/1568009619666181210114559
6. Pennell NA, Arcila ME, Gandara DR, West H (2019) Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices. Am Soc Clin Oncol Educ Book 39: 531-542. doi: 10.1200/EDBK_237863
7. Hartweg DL, Metcalfe SA (2022) Orem's Self-Care Deficit Nursing Theory: Relevance and Need for Refinement. Nurs Sci Q 35 (1): 70-76. doi: 10.1177/08943184211051369
8. He K, Li Q, Hou Y, He Y, Yue X (2021) Effect of a refined nursing model based on nursing quality feedback on the postoperative mental state of patients with laryngeal cancer. Am J Transl Res 13 (6): 6525-6533. doi:
9. Hall VL, Hardwick M, Reden L, Pulido P, Colwell C, Jr. (2004) Unicompartmental knee arthroplasty (alias uni-knee). An overview with nursing implications. Orthop Nurs 23 (3): 163-171; quiz 172-163. doi: 10.1097/00006416-200405000-00003
10. Alexander M, Kim SY, Cheng H (2020) Update 2020: Management of Non-Small Cell Lung Cancer. Lung 198 (6): 897-907. doi: 10.1007/s00408-020-00407-5
11. Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S, Committee EG (2017) Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28 (suppl_4): iv1-iv21. doi: 10.1093/annonc/mdx222
12. Muthusamy B, Patil PD, Pennell NA (2022) Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 20 (8): 953-961. doi: 10.6004/jnccn.2022.7021
13. Meng J, Du J, Diao X, Zou Y (2022) Effects of an evidence-based nursing intervention on prevention of anxiety and depression in the postpartum period. Stress Health 38 (3): 435-442. doi: 10.1002/smi.3104
14. Hsu ML, Naidoo J (2020) Principles of Immunotherapy in Non-Small Cell Lung Cancer. Thorac Surg Clin 30 (2): 187-198. doi: 10.1016/j.thorsurg.2020.01.009
15. Svaton M (2021) Targeted therapy of non-small cell lung cancer. Klin Onkol 34 (Supplementum 1): 48-52. doi: 10.48095/ccko2021S48
16. DeCamp MM, Jr., McKenna RJ, Jr., Deschamps CC, Krasna MJ (2008) Lung volume reduction surgery: technique, operative mortality, and morbidity. Proc Am Thorac Soc 5 (4): 442-446. doi: 10.1513/pats.200803-023ET
17. Yu L, Dong R, Lv Y, Shi S, Xue H, Miao J, Yu J (2023) Investigating Genetic Factors and the Effect of Refined Multidisciplinary Clinical Management on the Quality of Life and Perceived Control Level of Breast Cancer Patients undergoing Surgery and its Morphological Diagnosis Parameters. Cell Mol Biol (Noisy-le-grand) 69 (4): 53-59. doi: 10.14715/cmb/2023.69.4.8
18. Seys D, Bruyneel L, Deneckere S, Kul S, Van der Veken L, van Zelm R, Sermeus W, Panella M, Vanhaecht K (2017) Better organized care via care pathways: A multicenter study. PLoS One 12 (7): e0180398. doi: 10.1371/journal.pone.0180398
19. Harada G, Gongora ABL, da Costa CM, Santini FC (2020) TRK Inhibitors in Non-Small Cell Lung Cancer. Curr Treat Options Oncol 21 (5): 39. doi: 10.1007/s11864-020-00741-z
20. Su H, Wen Y, Kang D (2022) Application of Refined Nursing Combined with Comprehensive Treatment of Traditional Chinese and Western Medicine in Gastrointestinal Dysfunction after Tumor Operation. Evid Based Complement Alternat Med 2022: 4957061. doi: 10.1155/2022/4957061
21. Rafei H, El-Bahesh E, Finianos A, Nassereddine S, Tabbara I (2017) Immune-based Therapies for Non-small Cell Lung Cancer. Anticancer Res 37 (2): 377-387. doi: 10.21873/anticanres.11330
22. Coster JN, Groth SS (2020) Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer. Surg Oncol Clin N Am 29 (4): 543-554. doi: 10.1016/j.soc.2020.07.001
23. Gravier FE, Smondack P, Prieur G, Medrinal C, Combret Y, Muir JF, Baste JM, Cuvelier A, Boujibar F, Bonnevie T (2022) Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis. Thorax 77 (5): 486-496. doi: 10.1136/thoraxjnl-2021-217242
Copyright (c) 2024 Yannan Zhang
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.